Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC
暂无分享,去创建一个
F. Pilleul | P. Saintigny | F. Ghiringhelli | O. Beuf | B. Leporq | A. Bouhamama | Khuram Faraz | M. Pérol | J. Foy | S. Ortiz-Cuaran | M. Boussageon | Jean-Philippe Foy